Investing

Sarepta Therapeutics : SRPT

SRPT

Stock Data

$22.14

$0.68 (2.98%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Sarepta Therapeutics Inc is a pioneering biopharmaceutical company dedicated to developing unique treatments for rare diseases, with a strong focus on RNA-targeted therapies, gene therapies, and genetic therapeutic modalities. It is known for producing EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, targeting duchenne muscular dystrophy among other conditions. The company is actively working on advancing its pipeline, including SRP-5051 and SRP-9003 for muscular dystrophies. Founded in 1980 and based in Cambridge, Massachusetts, Sarepta collaborates with leading institutions to push the boundaries of genetic medicine.

All Sarepta Therapeutics Articles

137 Articles

Trey Thoelcke | Feb 5, 2025 at 8:45 AM EST

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Trey Thoelcke | Aug 25, 2024 at 9:15 AM EDT

NFL Team Owner Boosts a Stake, and Other Notable Insider Buying

An NFL team owner continues to boost a stake in an energy stock. Insiders made notable purchases in tech and…

Trey Thoelcke | Aug 6, 2024 at 9:15 AM EDT

Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Trey Thoelcke | Nov 14, 2023 at 8:40 AM EST

Huge Insider Buys at Energy Giants, Bill Ackman Boosts Real Estate Stake Again

Exxon Mobil and another energy giant saw huge insider buys this week, while Bill Ackman continued to build his stake…

Lee Jackson | Jun 26, 2023 at 8:47 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Accenture, Moderna, Tesla, Under Armour, Wayfair, Welltower and More

Monday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Accenture, Clorox, Fiserv, Moderna, Planet Fitness, Sarepta Therapeutics, Tesla,…

Lee Jackson | May 30, 2023 at 8:53 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Caterpillar, CVS Health, Marvell Technology, Paramount, RingCentral, SoFi, UnitedHealth, Workday and More

Tuesday's top analyst upgrades and downgrades included Broadcom, Caterpillar, CVS Health, Guardant Health, Marvell Technology, Nutrien, Paramount Global, RingCentral, SoFi…

Lee Jackson | Apr 27, 2023 at 8:51 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Albertsons, Alphabet, Apple, Coinbase, General Electric, McDonald’s, Microsoft, Tesla and More

Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General…

Lee Jackson | Apr 5, 2023 at 8:54 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: American Express, Analog Devices, Boeing, Chevron, Comcast, CSX, Etsy, Prudential Financial and More

Wednesday's top analyst upgrades and downgrades included American Express, Analog Devices, Boeing, Chevron, Chipotle Mexican Grill, Comcast, CSX, Etsy, Fastenal,…

Lee Jackson | Mar 20, 2023 at 8:50 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Alphabet, Dollar General, FedEx, Microsoft, Nike, Nvidia, Shopify, Synchrony, Warner Bros Discovery and More

Monday's top analyst upgrades and downgrades included Alphabet, Bill, Bumble, Dollar General, FedEx, FMC, Jabil Circuit, Microsoft, Nike, Nvidia, Sarepta…

Lee Jackson | Mar 10, 2023 at 8:39 AM EST

Friday’s Top Analyst Upgrades and Downgrades: AMD, Etsy, Meta Platforms, Salesforce, Sysco, Teladoc Health and More

Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Asana, Etsy, Exact Sciences, Guardant Health, Hilton Worldwide, Meta Platforms,…

Lee Jackson | Mar 2, 2023 at 8:46 AM EST

Thursday’s Top Analyst Upgrades and Downgrades: AbbVie, Boeing, Coupang, First Solar, Goldman Sachs, Johnson & Johnson, Monster Beverage, Rivian, Workday and More

Thursday's top analyst upgrades and downgrades included AbbVie, AutoZone, Boeing, Coupang, First Solar, Fortinet, Goldman Sachs, Johnson & Johnson, Marqeta,…

Chris Lange | Dec 16, 2022 at 11:30 AM EST

Will Markets Turn Even Lower? Analysts Upgrade or Downgrade American Airlines, Meta Platforms and More

Friday’s additional top analyst upgrades and downgrades were on Alaska Air, American Airlines, Meta Platforms, New York Times, Southwest Airlines,…

Lee Jackson | Nov 28, 2022 at 8:54 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Activision Blizzard, Amazon, Deere, DraftKings, Meta Platforms, Redfin, Tyson Foods, Visa, Wynn Resorts and More

Monday's top analyst calls were on Activision Blizzard, Amazon.com, Bilibili, Coupa Software, Deere, DraftKings, JD.com, Lufax, Meta Platforms, Redfin, Tyson…

Chris Lange | Aug 4, 2022 at 3:12 PM EDT

Barclays Has 3 Big Names With Massive Upside

Barclays recently issued a few calls across multiple industries implying serious upside for each stock, but one in particular with…

Lee Jackson | Apr 5, 2022 at 8:59 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Analog Devices, Caesars, Chevron, Hertz, Li Auto, Starbucks, Tesla, Twitter and More

Tuesday's top analyst upgrades and downgrades included Analog Devices, Baxter, BorgWarner, Caesars Entertainment, CarMax, Chevron, Hertz Global, Li Auto, Starbucks,…